Mumbai, June 19 -- Pharma major, Alembic Pharma on Thursday said that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.
The inspection was conducted from March 17 to March 21.
UNI JS SS
Published by HT Digital Content Services with permission from United News of India....